CORONAVIRUS MEANS TELETHEALTH IS THE NEW NORM – EVEN FOR PHARMA SALES REPS
The impacts of Coronavirus disease 2010 (COVID-19) are just beginning to be felt, but the emergence of alternative ways to do business during this time will be a critical indicator of where we are headed in healthcare and pharma marketing.
Our POV addresses the challenge and recommends strategies pharma marketers can leverage during this global health crisis.